“…While some studies have localized the area of greatest degenerative change to the anterior fusiform or inferior temporal gyrus , others consider the temporal pole (Mummery et al, 2000;Galton et al, 2001;Davies et al, 2009;Rohrer et al, 2009), entorhinal cortex (Chan et al, 2001), or perirhinal cortex (La Joie et al, 2014) to be the most prominent region of neurodegeneration. Although these discrepancies might be the result of biological variability between samples, they may also arise from differences in the neuroimaging analysis techniques used, which include voxel-based (VBM; Mummery et al, 2000;Gorno-Tempini et al, 2004;Seeley et al, 2009), manual region of interest tracing (Chan et al, 2001;Galton et al, 2001), cortical thickness analyses (Rohrer et al, 2009), or voxel-based analysis of hypometabolism obtained using 18 Fluorodeoxyglucose (FDG-PET; La Joie et al, 2014). No studies have attempted to assess the reliability of effects across multiple samples of patients with svPPA.…”